Pipeline
CV6 Therapeutics is building a pipeline of therapies designed to improve the effectiveness of cornerstone treatments in cancer and inflammatory diseases.
Our lead clinical asset, CV6-168, is engineered to work in combination with widely used therapies, enhancing their impact without adding toxicity. Additional programs extend this strategy into new disease areas.
CV6-000
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque condimentum dui semper lorem sagittis iaculis. Sed rutrum libero ut ex blandit, sed sagittis nisi aliquam. Ut lorem eros, feugiat non ullamcorper sit amet, consequat ut eros. Proin vel mollis diam.
Vestibulum euismod tincidunt velit. Duis tincidunt velit nec mauris mattis aliquam. Mauris sodales eleifend sapien, finibus ornare sem viverra vitae. Nam accumsan facilisis dolor semper elementum. Suspendisse luctus consequat tristique. Suspendisse viverra molestie vulputate. In malesuada aliquam sapien id ultricies.
If CV6-168 performs as expected, it could fundamentally change how we use 5-FU in cancer treatment.